LUNG ADENOCARCINOMA
Clinical trials for LUNG ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LUNG ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a new drug combo shrink tough lung tumors?
Disease control OngoingThis study tests whether adding the drug veliparib to standard chemotherapy and radiation helps people with stage III lung cancer that can't be removed by surgery. About 53 adults took part to find the best dose and see if the combination slows cancer growth. The goal is to impro…
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
Radiation boost may improve immunotherapy for tough lung cancers
Disease control TerminatedThis study looks at whether adding radiation therapy to standard immunotherapy (with or without chemotherapy) can help people with advanced non-small cell lung cancer that is PD-L1 negative. About 427 participants with stage IIIB to IV lung cancer will be randomly assigned to rec…
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 23:36 UTC
-
Can adding surgery or radiation to immunotherapy improve survival in advanced lung cancer?
Disease control OngoingThis phase 3 trial studies whether adding local treatments like surgery or radiation to immunotherapy (nivolumab and ipilimumab) helps people with stage IV non-small cell lung cancer live longer. About 339 participants will receive immunotherapy alone or with additional local the…
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 16, 2026 23:36 UTC
-
New cocktail for inoperable lung cancer shows promise in early trial
Disease control OngoingThis study tested a three-part treatment for people with stage III lung cancer that cannot be removed by surgery. The treatment combined standard chemotherapy (cisplatin and etoposide) with radiation, followed by two additional drugs (docetaxel and bevacizumab) to try to kill mor…
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New targeted drug shows promise for Hard-to-Treat lung cancer
Disease control OngoingThis study tests a drug called AMG 510 in people with advanced lung cancer that has a specific genetic change (KRAS G12C). The drug targets this change to stop cancer growth. About 116 participants will receive the treatment to see if it shrinks tumors and how safe it is.
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC